← Evidence map

ReviewDiabetologia2017

PCSK9 inhibition: the dawn of a new age in cholesterol lowering?

David Preiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2017
2018
2019
2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28025677